This reduction in estrogen levels decreases the activation of estrogen receptors, curbing cell proliferation, and limiting the growth of estrogen receptor (ER)-positive cancer cells, while the increase in androgens promotes the activation of androgen receptors, enhancing growth inhibition. This evidence concerns the gene ESR1 and cancer.